US Patent 10689400 Macrocycle kinase inhibitors
Patent 10689400 was granted and assigned to Turning Point Therapeutics on June, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 27, 2017
Date of Patent
June 23, 2020
Patent Applicant
Patent Application Number
16320589
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10689400 Macrocycle kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
